J. Randolph Hecht - Departments of Pathology and Laboratory Medicine, Medicine and Pediatrics, University of California at Los Angeles

基本信息

浏览量：107

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 251 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Intratumoral or Subcutaneous MK-2118, a Non-Cyclic Dinucleotide STING Agonist, with or Without Pembrolizumab for Advanced or Metastatic Solid Tumors or Lymphomas

Jason J Luke,Randy F Sweis,J Randolph Hecht,Reva Schneider,Mark N Stein,Talia Golan,Timothy A Yap,Anuradha Khilnani,Mo Huang, Runchen Zhao,Thomas Jemielita,Sandip Pravin Patel

Clinical cancer research an official journal of the American Association for Cancer Researchno. 7 (2025): 1233-1242

引用0浏览0WOS引用

A Phase 1b/2 Study of the Anti-CD47 Antibody Magrolimab with Cetuximab in Patients with Colorectal Cancer and Other Solid Tumors

Cathy Eng,Nehal J. Lakhani,Philip A. Philip,Charles Schneider, Benny Johnson,Adel Kardosh,Mark P. Chao,Amita Patnaik, Fadi Shihadeh, Yeonju Lee, Kai Song, Denise Jin, Yanan Huo, Michael Howland,George A. Fisher,J. Randolph Hecht

Targeted Oncologyno. 3 (2025): 519-530

引用0浏览0WOS引用

Characteristics of Patients and Prognostic Factors Across Treatment Lines in Metastatic Colorectal Cancer: an Analysis from the Aide Et Recherche En Cancérologie Digestive Database

Jean-Baptiste Bachet,Aimery de Gramont,Morteza Raeisi,Manel Rakez, Richard M Goldberg, Niall C Tebbutt,Eric Van Cutsem, Daniel G Haller,J Randolph Hecht,Robert J Mayer,Stuart M Lichtman, Al B Benson, Alberto F Sobrero,Josep Tabernero,Richard Adams, John R Zalcberg,Axel Grothey,Takayuki Yoshino,Thierry André,Qian Shi,Benoist Chibaudel

Journal of clinical oncology official journal of the American Society of Clinical Oncologyno. 18 (2025): 2094-2106

引用0浏览0WOS引用

CITRINO: Phase 1 Dose Escalation Study of Anti-Lag-3 Antibody Encelimab Alone or in Combination with Anti-Pd-1 Dostarlimab in Patients with Advanced/metastatic Solid Tumours

J Randolph Hecht,Jean-Marie Michot, David Bajor,Amita Patnaik, Ki Y Chung,Judy Wang,Gerald Falchook,James M Cleary, Richard Kim, Anuradha Krishnamurthy, Omkar Marathe,Hagop Youssoufian,Catherine Ellis, Angela Waszak,Srimoyee Ghosh, Hailei Zhang, Kaitlin Yablonski, Shruti D Shah, Ivan Diaz-Padilla,Susanna Ulahannan

BJC reportsno. 1 (2025): 10-10

引用0浏览0WOSNATURE引用

Updated Safety and Efficacy from a Phase 1 Study of RMC-6236, a RAS (ON) Multi-Selective, Tri-Complex Inhibitor, in Patients with RAS Mutant Pancreatic Ductal Adenocarcinoma (PDAC)

B. Wolpin,D. Hong,A. Spira,A. Starodub, W. Park,D. Sommerhalder, J. Valerin,M. Barve, S. Punekar,M. Pelster, B. Herzberg, N. Azad, K. Aung,J. R. Hecht, L. Cheng, R. Vora, Z. Salman, Y. Zhang, T. Lin, I. Garrido-Laguna

EUROPEAN JOURNAL OF CANCER (2024): S183-S184

引用0浏览0引用

Abstract CT078: Phase 1 Study of SGN-EGFRd2 in Solid Tumors (Sgnegfrd2-001)

Hirva Mamdani,Joel Randolph Hecht,Rachel E. Sanborn,Maria Corinna Palanca-Wessels,Mingjin Yan,Martin Gutierrez,David L. Bajor

Cancer Researchno. 7_Supplement (2024)

引用0浏览0引用

Open-label, Phase 1, Multicenter Study to Evaluate the Safety and Preliminary Anti-Tumor Activity of NT-175 in Human Leukocyte Antigen-A*02:01-Positive Adult Subjects with Unresectable, Advanced And/or Metastatic Solid Tumors That Are Positive for the TP53 R175H Mutation

Carlos Becerra,Mark M. Awad,J. Randolph Hecht,Andrew Scott Paulson, Jennifer Lee, Gabi Palluconi, John P. Dalton,Anuradha Patel, Ying Yan,Arianne Perez,Sunny Xie, Sarah S. Cohen,Marwan Fakih

Journal of Clinical Oncologyno. 16_suppl (2024): e14514-e14514

引用0浏览0引用

662 A Phase1 Study of Autologous Engineered CD4+ and CD8+ T Cells, HLA-A*11:01-restricted, KRAS G12V-specific, Transgenic TCR; CD8α/β Coreceptor and a FAS41BB Switch Receptor in Patients with Solid Tumors

Shaunica Mitchell, Binaish Khan,Francis Payumo,E Gabriela Chiorean,Zhubin Gahvari,J Randolph Hecht,Michael Hurwitz,Rom S Leidner,Heinz-Josef Lenz,Meredith Pelster,Adam J Schoenfeld,Salman R Punekar,Dan Zhao, Soumit Basu,Dirk Nagorsen

Regular and Young Investigator Award Abstracts (2024)

引用0浏览0引用

STELLAR-303: A Randomized Phase 3 Study of Zanzalintinib (XL092) Plus Atezolizumab Versus Regorafenib in Previously Treated Metastatic Colorectal Cancer

Anwaar Saeed,Josep Tabernero,Guan Wang, Xia Ma,Robina Smith,J. Randolph Hecht

Journal of Clinical Oncologyno. 16_suppl (2024): TPS3634-TPS3634

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn